Metastatic Prostate Cancer
Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer
... of metastatic prostate cancer presenting with progressive renal dysfunction, which was augmented by ...when prostate cancer patients present with renal dysfunction due to unknown ...
5
New Molecular Targets in Metastatic Prostate Cancer
... Prostate cancer (PCa) is the second leading cause of cancer death in ...castration-resistant prostate cancer ...in metastatic prostate ...
14
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer — A Canadian consensus statement
... The current recommendations for management of recurrent or metastatic prostate cancer are based on available evidence and expert consensus regarding standards of current practice. The described ...
20
The effect of race on survival after local therapy in metastatic prostate cancer patients
... Local therapy (LT) may offer a survival advantage in highly select patients with newly diagnosed metastatic prostate cancer (mPCa) according to several retrospective studies [ 1–10 ]. Nonetheless, ...
12
Metastatic prostate cancer presenting with hoarseness
... differentiated prostate adenocarcinoma, Gleason score 7 with bilateral extracapsular and perineural ...initial prostate-specific antigen (PSA) level was ...revealed metastatic prostate ...
6
Metastatic Prostate Cancer
... with prostate cancer is a major global health care challenge, compounded by an aging population and increasing frequency of ...of metastatic disease, which continues to be associated with a high rate ...
13
Cost effectiveness of docetaxel in high volume hormone sensitive metastatic prostate cancer
... An economic model was constructed to conduct a cost-effectiveness analysis and a cost-utility analysis following the guidelines outlined by CADTH. 18 A partitioned survival model was developed for high-volume ...
16
Management algorithms for metastatic prostate cancer
... “prostate cancer AND (guideline OR consensus OR recommendations)” and guideline databases (Canadian Medical Association’s CPG Infobase: Clinical Practice Guidelines, National Guidelines Clearinghouse, and ...
11
Multiparametric liquid biopsy analysis in metastatic prostate cancer
... At each liquid biopsy time point, 3 tubes of blood were processed simultaneously for CTC count, somatic single nucleotide variants (SSNVs) derived from CTCs and matched cfDNA, copy number variant (CNV) analysis derived ...
11
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
... of Cancer Research (ICR), developed abiraterone ace- tate and has a commercial interest in this drug, and he is on the ICR’s list of rewards to inventors of abiraterone ...
12
SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion
... breast cancer cells, SATB1 coor- dinates the expression of a large number of genes to in- duce ...breast cancer cells not only reversed metastatic pheno- types but also inhibited tumor growth, ...
10
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
... Prostate cancer (PCa) is the second most common can- cer and third most leading cause of death of men in the western world ...invasive prostate biopsies, which are indicated by elevated ...
6
Immune-based therapies for metastatic prostate cancer: An update
... Plasmid DNA encoding PAP: The pTVG-HP plasmid encoding the PAP protein has been well studied in preclinical and clinical settings [71]. In a phase I human clinical trial, pTVG-HP/PAP induces PAP-specific interferon ...
30
Management algorithms for metastatic prostate cancer
... diagnosed metastatic castration-resistant prostate ...for metastatic castration-sensitive prostate cancer; 4 PSA progression as defined by PCWG2 criteria; 5 Consider palliative care ...
24
The Revitalization of the Community based Management of Acute Malnutrition Program in Haiti
... normal prostate tissue and primary prostate cancer ...The metastatic prostate cancer tissues studied here that were obtained from bone have higher CaSR expression than primary ...
192
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer
... in metastatic prostate cancer ...in metastatic prostate cancer samples (n = ...from prostate cancers expressing high and low levels of ...the prostate cancer ...
17
Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model
... PCa: prostate cancer; PPCa: primary prostate cancer; MPCa: metastatic prostate cancer; LIMMA: linear models for microarray data analysis; eBayes: the empiri- cal bayes; ...
16
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
... The primary treatment modality for patients with metastatic prostate cancer is androgen deprivation therapy (ADT). However, treatment is uniformly marked by progres- sion to CRPC over a period of ...
13
MANAGEMENT OF BONE METASTASIS THROUGH HERBAL DRUGS A REVIEW
... for metastatic prostate cancer on human prostate tumor xenografts in the tibia of ...-independent prostate cancer cells as well as of bone marrow, bone marrow-derived endothelial ...
13
Role of splice variants in the metastatic progression of prostate cancer
... only cancer cells will be targeted, decreasing toxicity towards normal ...against cancer-specific variants in metastatic prostate ...of prostate cancer cells may also result in ...
5